Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure

Clinical trial NCT01252810 · COMPLETED

Trial details

NCT number: NCT01252810
Sponsor: GE Healthcare
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Renal Insufficiency Diabete Mellitus Congestive Heart Failure

Start date: 2010-11-01
Primary completion: 2012-12-01
Enrollment: 284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.